Loading...
XSHG
603351
Market cap506mUSD
Jul 09, Last price  
25.36CNY
1D
-2.08%
1Q
-2.01%
IPO
-18.56%
Name

Nanjing Well Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:603351 chart
P/E
22.75
P/S
2.57
EPS
1.11
Div Yield, %
1.58%
Shrs. gr., 5y
0.84%
Rev. gr., 5y
12.65%
Revenues
1.34b
+2.95%
527,598,124498,690,764558,443,861694,110,645801,451,310880,756,050736,063,7481,042,305,9141,111,010,6821,155,839,7761,296,753,3881,335,037,035
Net income
151m
+3.11%
44,827,77560,671,30085,032,795107,432,224111,814,360128,107,854100,446,708101,370,21095,028,728112,199,194146,421,829150,968,971
CFO
238m
+7.42%
74,615,18581,135,872128,181,46671,271,47463,758,147129,694,09993,304,3520108,989,026120,243,703221,793,445238,244,935
Dividend
Jun 13, 20250.4 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanjing Well Pharmaceutical Group Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical excipients within the Chinese market. These essential auxiliary materials are utilized in both injectable and non-injectable drug formulations. Beyond its pharmaceutical focus, the company also supplies an extensive range of synthetic base oils for various industrial applications, including hydraulic fluids, lubricity additives for metals, metal quenching agents, compression lubricants, gear oils, chain lubricants, and base stocks for engine oils, heat transfer oils, and greases. Furthermore, its product portfolio diversifies into other specialized chemicals such as paints and coatings, textile chemicals, field chemicals, and low-foam metal cleaners. The company boasts a global presence, exporting its products to key markets in Europe, the United States, Southeast Asia, and other international regions. Originally known as Nanjing Well Pharmaceutical Co., Ltd., the company officially adopted its current name, Nanjing Well Pharmaceutical Group Co., Ltd., in April 2020.
IPO date
Jan 30, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT